Dexamethasone Market - Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026: The Rise of Dexamethasone as a Lifesaving Treatment for Critically Ill COVID-19 Patients - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 7, 2021--
The “Dexamethasone Market By Formulation type, By Application, and End user - Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026” report has been added to ResearchAndMarkets.com’s offering.
The report covers forecast and analysis for the Dexamethasone market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion).
The study includes drivers and restraints for the Dexamethasone market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Dexamethasone market on a global as well as regional level.
In order to give the users of this report a comprehensive view on the Dexamethasone market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein Formulation type, Patient type, Application, End user, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the Dexamethasone market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the Dexamethasone market on global and regional basis.
- The rise of dexamethasone as a lifesaving treatment for critically ill COVID-19 patients due to a sudden outburst
- Increasing various inflammatory conditions
- Growing prevalence of diseases
- Side effects associated with use of Dexamethasone
- High investment in research and development in Dexamethasone market
Porter’s Five Forces Analysis
The report segments global Dexamethasone market as follows:
Global Dexamethasone Market: Formulation type
- Solution for injection
Global Dexamethasone Market: By Patient type
Global Dexamethasone Market: By Application
- Anti-inflammatory and immunosuppressant effects
- Respiratory Distress Syndrome
Global Dexamethasone Market: By End user
- Pharmacy & Drug Stores
- Online Pharmacies
Global Dexamethasone Market: By Region
- North America
- The U.S.
- The UK
- Rest of Europe
- Asia Pacific
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa
- Cadila Healthcare Ltd.
- Wockhardt Ltd
- Fresenius Kabi
- Dwarkesh Pharmaceuticals Private Limited
- Schwitz Biotech
- Lexine Technochem Private Limited
- Mapro Lifescience
- Therawin Formulations
- Shervotec Pharmaceuticals
- Therawin Formulations
- Acichem Laboratories
- Quality Nexgen Pharmaceuticals Pvt Ltd
- Kern Pharma SL
- Symbiotic Pharma
For more information about this report visit https://www.researchandmarkets.com/r/h2b1ks
View source version on businesswire.com:https://www.businesswire.com/news/home/20210107005726/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 01/07/2021 11:42 AM/DISC: 01/07/2021 11:42 AM